Developer docs
API playgroundTry for free, no card

Search company profiles

Bionics Institute

Full company profile

uuid000qdw3

Namestring
Bionics Institute
Legal namestring
Bionics Institute
Company typeenum
Private
Founded yearint
1986
Descriptiontext

The Bionics Institute is a non-profit medical research institute founded in 1986 in Melbourne, Australia, by Professor Graeme Clark — inventor of Australia's cochlear implant, which has since been used by over 600,000 deaf people globally. The institute develops implantable medical devices, neuromodulation technologies, and diagnostic platforms targeting hearing impairment, vision loss, neurological conditions (epilepsy, Alzheimer's, Parkinson's disease, stroke), autoimmune and chronic inflammatory diseases (Crohn's disease, rheumatoid arthritis), and movement and balance disorders. Patient cohorts are reached primarily through clinical trials and commercialized spin-off products rather than direct sales.

The institute's technology portfolio includes the FDA-authorized EpiMinder implantable brain monitor for drug-resistant epilepsy, the EarGenie paediatric audiology diagnostic device, an abdominal vagus nerve stimulation device (first implanted in a Crohn's patient in 2023), the bionic eye for retinitis pigmentosa (with 2.5-year clinical follow-up showing substantial vision improvements), transcranial magnetic stimulation software for depression and Alzheimer's, tinnitus objective measurement technology, and transcranial random noise stimulation for perimenopausal brain fog. The institute also operates specialized pre-clinical, histology, engineering, and clinical testing services (including fNIRS, 64-channel EEG, audiometry, and psychophysics systems) available to external researchers, clinicians, start-ups, and ASX-listed companies. Four spin-off companies (EpiMinder, Neo-Bionica, EarGenie, Deep Brain Stimulation Technologies) provide the commercialization pathway, with EpiMinder having secured both FDA authorization and an ASX listing in 2025.

The institute is funded through a diversified mix of tax-deductible donations, government grants (NHMRC, MRFF, Victorian Government), impact and equity investment, fee-for-service contract research, and equity-related returns from spin-off companies. Revenue from commercialization is reinvested into research. Operating from laboratories at St Vincent's Hospital Melbourne with a planned 2025 relocation to the new ACMD building (Australia's first hospital-based bioengineering research centre), the institute employs 101-250 staff and maintains strategic affiliations with Swinburne University of Technology and the University of Melbourne.

Short descriptiontext

The Bionics Institute is an Australian non-profit medical research institute developing implantable neuromodulation devices, diagnostic tools, and neurotechnology for hearing impairment, vision loss, epilepsy, and inflammatory diseases, commercialized through a portfolio of in-house research and four spin-off companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersFitzroy, Australia
HQ citystring
Fitzroy
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device research, neuromodulation technologies, contract research services, preclinical research, bionic implants
Industry2 codes
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code5 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical Laboratories621511
  • Surgical Appliance and Supplies Manufacturing339113
SIC code4 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Medical Device Research & Development
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Donations and Philanthropy
TypeGrants Donations
Description

Tax deductible donations fund early-stage conceptual research and initial research trials. Multiple giving programs including regular giving, workplace giving, leave a gift in will, corporate giving, and tribute giving.

bionicsinstitute.org
2Government Grants
TypeGrants Donations
Description

Funding from government bodies including NHMRC (National Health and Medical Research Council), MRFF (Medical Research Future Fund), and Victorian Government grants for specific research projects.

bionicsinstitute.org
3Impact and Equity Investment
TypeOthers
Description

Impact investment and equity investment enables translation of ground-breaking research into clinical reality. Investment in spin-off companies funds future research at the institute.

bionicsinstitute.org
4Contract Research Services
TypeProfessional Services
Description

Provides research services to external researchers, clinicians, start-ups, university groups, and ASX listed companies including pre-clinical research, histology, engineering, and clinical testing.

bionicsinstitute.org
5Spin-off Company Revenue
TypeLicensing Royalties
Description

Establishment of spin-off companies (EpiMinder, Neo-Bionica, Deep Brain Stimulation Technologies) staffed with experts to commercialise innovations, with investment in these companies funding future institute research.

bionicsinstitute.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bionics Institute is a non-profit medical research institute that develops implantable medical devices and neuromodulation technologies for hearing, vision, neurological and inflammatory conditions. It also provides fee-for-service contract research capabilities spanning pre-clinical studies, histology, engineering and prototype manufacturing, and specialised clinical testing for external researchers, clinicians and industry clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 600,000 deaf people worldwide have received hearing through cochlear implants developed by Bionics Institute
+4 more records
Product overview1 text field

The Bionics Institute is a non-profit medical research institute that develops medical devices and provides contract research services. Its product portfolio includes both commercialized spin-off products (EpiMinder for epilepsy monitoring, EarGenie for infant hearing diagnostics, Neo-Bionica for engineering services) and pipeline devices in development (cochlear implants, bionic eye, vagus nerve stimulation for Crohn's disease and rheumatoid arthritis, TMS software for Alzheimer's treatment, tinnitus diagnostics). The Institute also offers fee-for-service contract research capabilities including pre-clinical research, histology services, engineering/prototype manufacturing, and specialized clinical testing facilities.

Product and service7 records
1EpiMinder Minder Device
CategoryMedical Device
Description

FDA-authorised implantable device providing continuous monitoring of brain activity to support management of drug-resistant epilepsy. Developed and commercialised via Bionics Institute spin-off EpiMinder Pty Ltd.

2EarGenie Paediatric Audiology Diagnostic
CategoryDiagnostic Device
Description

Innovative diagnostic device for paediatric audiology that guides programming of hearing aids and cochlear implants, bringing clarity to infant hearing assessment.

3Neo-Bionica Engineering Services
CategoryContract Engineering Service
Description

Specialised engineering support services for neurotechnology innovators, providing assistance in developing implants from concept to clinical trials.

4Pre-clinical Research Services
CategoryContract Research Service
Description

Comprehensive pre-clinical research services including small-to-large animal models, disease models, electrophysiology, and behavioural assessments for external researchers, clinicians and industry clients.

5Histology and In-vitro Services
CategoryContract Research Service
Description

Integrated histology and imaging services including tissue processing, immunofluorescence staining, cell culturing, and microscopic analysis for medical device and biomedical research clients.

6Engineering and Prototype Manufacturing Services
CategoryContract Engineering Service
Description

End-to-end engineering support including product design, mechanical and electrical design, embedded firmware, electrode design and fabrication, device and system prototyping, and surgical methods and tooling development.

7Specialised Clinical Testing Facilities
CategoryContract Clinical Testing Service
Description

Clinical testing facilities offering optical brain monitoring (fNIRS), audiometry, tympanometry, 64-channel EEG measurement systems, and specialist psychophysics systems for external research clients.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership23 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key clinical collaborator where Bionics Institute laboratories are based. Partnership includes collaboration on ACMD (Australia's first hospital-based bioengineering research centre).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bionics Institute is proudly affiliated with Swinburne University. Strategic alliance announced in November 2025 for research collaboration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Melbourne Department of Medical Bionics is located at the Bionics Institute. Close affiliation with Department of Biomedical Engineering.

Strategic tierCoreTypeTechnology or Integration
Description

Commercial collaborator for cochlear implant technology development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Commercial collaborator for bionic eye research and development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spin-off company from Bionics Institute developing implantable continuous monitoring for epilepsy, now listed on ASX.

7Deep Brain Stimulation Technologies Pty Ltd
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spin-off company from Bionics Institute for deep brain stimulation technology.

bionicsinstitute.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spin-off company providing specialised engineering support to neurotechnology innovators to develop implants from concept to clinical trials.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Clinical collaborator for research projects.

10Austin Health
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Clinical collaborator for research projects.

bionicsinstitute.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Clinical collaborator for research projects.

12Monash University
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research collaborator in the Australian university system.

bionicsinstitute.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research collaborator in the Australian university system.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research collaborator in the Australian university system.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International research collaborator in the UK.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International research collaborator in Germany.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research collaborator in neuroscience.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research collaborator for vision-related research.

19ACMD (Australian Centre for Bioengineering)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Australia's first hospital-based bioengineering research centre located at St Vincents Hospital. Bionics Institute is a key partner and will move into the new ACMD building.

bionicsinstitute.org
20Medical Device Partnering Programme (MDPP)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Network partner for medical device development.

bionicsinstitute.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Network partner supporting innovation and women in STEM through Girls in STEM Mentoring Program.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Clinical collaborator for research projects.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Clinical collaborator for hearing and vision research.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based company behind the RNS System, an FDA-approved implantable brain stimulation device for drug-resistant epilepsy. Closest direct peer to Bionics Institute's EpiMinder device, addressing the same patient population with similar implantable neurotechnology architecture.

TypeEmerging player
Description

Smaller neuromodulation company commercializing non-invasive vagus nerve stimulation (nVNS) for headache and inflammatory conditions. Overlaps with Bionics Institute's vagus nerve stimulation research but uses a non-invasive delivery approach rather than the institute's implantable method.

TypeBroad incumbent
Description

Global medical device incumbent with the largest neuromodulation portfolio (spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, targeted drug delivery). Competes broadly with Bionics Institute across multiple pipeline areas including DBS and cochlear-adjacent neurotechnology.

TypeDirect peer
Description

Global neuromodulation company with a leading vagus nerve stimulation (VNS) platform used for drug-resistant epilepsy and treatment-resistant depression. Direct peer to Bionics Institute's vagus nerve stimulation programs and a benchmark for scaling neuromodulation indications.

TypeDirect peer
Description

Global leader in cochlear implant devices, headquartered in Australia. Bionics Institute is the original scientific developer of the cochlear implant technology and remains a research collaborator/licensor to Cochlear Limited, making them the most direct peer commercially and scientifically.

TypeEmerging player
Description

Australia/US neuromodulation company developing closed-loop spinal cord stimulation. Comparable emerging player in the implantable neurostimulation category where Bionics Institute operates, addressing chronic pain and neurological indications.

TypeBroad incumbent
Description

Diversified medical device incumbent with a major neuromodulation franchise (Proclaim spinal cord stimulators, Infinity DBS). Operates in the same broader neuromodulation market as Bionics Institute with vastly greater commercialization scale.

TypeDirect peer
Description

US-based cochlear implant manufacturer (acquired by Sonova). Operates in the same hearing restoration device category as Bionics Institute cochlear research, targeting similar patients and clinical use cases.

TypeDirect peer
Description

Austria-based global cochlear implant manufacturer competing directly in the hearing restoration market where Bionics Institute cochlear research operates. Comparable in product category, clinical use case, and patient population.

TypeDirect peer
Description

Australian bionic eye developer and listed commercial collaborator of Bionics Institute. Directly comparable for bionic eye research targeting retinitis pigmentosa, with overlapping patient population and technology basis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bionics Institute

Medical Device Research & Developmentbionicsinstitute.org

The Bionics Institute is an Australian non-profit medical research institute developing implantable neuromodulation devices, diagnostic tools, and neurotechnology for hearing impairment, vision loss, epilepsy, and inflammatory diseases, commercialized through a portfolio of in-house research and four spin-off companies.

What Bionics Institute does

The Bionics Institute is a non-profit medical research institute founded in 1986 in Melbourne, Australia, by Professor Graeme Clark — inventor of Australia's cochlear implant, which has since been used by over 600,000 deaf people globally. The institute develops implantable medical devices, neuromodulation technologies, and diagnostic platforms targeting hearing impairment, vision loss, neurological conditions (epilepsy, Alzheimer's, Parkinson's disease, stroke), autoimmune and chronic inflammatory diseases (Crohn's disease, rheumatoid arthritis), and movement and balance disorders. Patient cohorts are reached primarily through clinical trials and commercialized spin-off products rather than direct sales.

The institute's technology portfolio includes the FDA-authorized EpiMinder implantable brain monitor for drug-resistant epilepsy, the EarGenie paediatric audiology diagnostic device, an abdominal vagus nerve stimulation device (first implanted in a Crohn's patient in 2023), the bionic eye for retinitis pigmentosa (with 2.5-year clinical follow-up showing substantial vision improvements), transcranial magnetic stimulation software for depression and Alzheimer's, tinnitus objective measurement technology, and transcranial random noise stimulation for perimenopausal brain fog. The institute also operates specialized pre-clinical, histology, engineering, and clinical testing services (including fNIRS, 64-channel EEG, audiometry, and psychophysics systems) available to external researchers, clinicians, start-ups, and ASX-listed companies. Four spin-off companies (EpiMinder, Neo-Bionica, EarGenie, Deep Brain Stimulation Technologies) provide the commercialization pathway, with EpiMinder having secured both FDA authorization and an ASX listing in 2025.

The institute is funded through a diversified mix of tax-deductible donations, government grants (NHMRC, MRFF, Victorian Government), impact and equity investment, fee-for-service contract research, and equity-related returns from spin-off companies. Revenue from commercialization is reinvested into research. Operating from laboratories at St Vincent's Hospital Melbourne with a planned 2025 relocation to the new ACMD building (Australia's first hospital-based bioengineering research centre), the institute employs 101-250 staff and maintains strategic affiliations with Swinburne University of Technology and the University of Melbourne.

Bionics Institute firmographics

Firmographics
Name
Bionics Institute
Legal name
Bionics Institute
Website
https://bionicsinstitute.org
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
101–250 employees
Short description
The Bionics Institute is an Australian non-profit medical research institute developing implantable neuromodulation devices, diagnostic tools, and neurotechnology for hearing impairment, vision loss, epilepsy, and inflammatory diseases, commercialized through a portfolio of in-house research and four spin-off companies.
Ownership category
akta.pro rank

Bionics Institute industry classification

Industry
Product category
Medical Device Research & Development
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Medical device research
  • Neuromodulation technologies
  • Contract research services
  • Preclinical research
  • Bionic implants

Where Bionics Institute is headquartered

Location

Headquarters

HQ city
Fitzroy
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Bionics Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Donations and Philanthropy: Tax deductible donations fund early-stage conceptual research and initial research trials. Multiple giving programs including regular giving, workplace giving, leave a gift in will, corporate giving, and tribute giving.
  2. Government Grants: Funding from government bodies including NHMRC (National Health and Medical Research Council), MRFF (Medical Research Future Fund), and Victorian Government grants for specific research projects.
  3. Impact and Equity Investment: Impact investment and equity investment enables translation of ground-breaking research into clinical reality. Investment in spin-off companies funds future research at the institute.
  4. Contract Research Services: Provides research services to external researchers, clinicians, start-ups, university groups, and ASX listed companies including pre-clinical research, histology, engineering, and clinical testing.
  5. Spin-off Company Revenue: Establishment of spin-off companies (EpiMinder, Neo-Bionica, Deep Brain Stimulation Technologies) staffed with experts to commercialise innovations, with investment in these companies funding future institute research.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Bionics Institute product offering

Product offering

Core offering

Bionics Institute is a non-profit medical research institute that develops implantable medical devices and neuromodulation technologies for hearing, vision, neurological and inflammatory conditions. It also provides fee-for-service contract research capabilities spanning pre-clinical studies, histology, engineering and prototype manufacturing, and specialised clinical testing for external researchers, clinicians and industry clients.

Product overview

The Bionics Institute is a non-profit medical research institute that develops medical devices and provides contract research services. Its product portfolio includes both commercialized spin-off products (EpiMinder for epilepsy monitoring, EarGenie for infant hearing diagnostics, Neo-Bionica for engineering services) and pipeline devices in development (cochlear implants, bionic eye, vagus nerve stimulation for Crohn's disease and rheumatoid arthritis, TMS software for Alzheimer's treatment, tinnitus diagnostics). The Institute also offers fee-for-service contract research capabilities including pre-clinical research, histology services, engineering/prototype manufacturing, and specialized clinical testing facilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • EpiMinder Minder Device FDA-authorised implantable device providing continuous monitoring of brain activity to support management of drug-resistant epilepsy. Developed and commercialised via Bionics Institute spin-off EpiMinder Pty Ltd.
  • EarGenie Paediatric Audiology Diagnostic Innovative diagnostic device for paediatric audiology that guides programming of hearing aids and cochlear implants, bringing clarity to infant hearing assessment.
  • Neo-Bionica Engineering Services Specialised engineering support services for neurotechnology innovators, providing assistance in developing implants from concept to clinical trials.
  • Pre-clinical Research Services Comprehensive pre-clinical research services including small-to-large animal models, disease models, electrophysiology, and behavioural assessments for external researchers, clinicians and industry clients.
  • Histology and In-vitro Services Integrated histology and imaging services including tissue processing, immunofluorescence staining, cell culturing, and microscopic analysis for medical device and biomedical research clients.
  • Engineering and Prototype Manufacturing Services End-to-end engineering support including product design, mechanical and electrical design, embedded firmware, electrode design and fabrication, device and system prototyping, and surgical methods and tooling development.
  • Specialised Clinical Testing Facilities Clinical testing facilities offering optical brain monitoring (fNIRS), audiometry, tympanometry, 64-channel EEG measurement systems, and specialist psychophysics systems for external research clients.

Quantifiable outcome

  • Over 600,000 deaf people worldwide have received hearing through cochlear implants developed by Bionics Institute
  • +4 more outcomes

Companies that use Bionics Institute

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Bionics Institute technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature9 records

Bionics Institute partnerships and signals

Strategic signal

Partnerships

23 partnerships are on record, tiered core, major and minor.

  • St Vincent's Hospital MelbournecoreStrategic or Co-development PartnerKey clinical collaborator where Bionics Institute laboratories are based. Partnership includes collaboration on ACMD (Australia's first hospital-based bioengineering research centre).
  • Swinburne University of TechnologycoreStrategic or Co-development PartnerBionics Institute is proudly affiliated with Swinburne University. Strategic alliance announced in November 2025 for research collaboration.
  • University of MelbournecoreStrategic or Co-development PartnerUniversity of Melbourne Department of Medical Bionics is located at the Bionics Institute. Close affiliation with Department of Biomedical Engineering.
  • Cochlear LtdcoreTechnology or IntegrationCommercial collaborator for cochlear implant technology development.
  • Bionic Vision TechnologiescoreStrategic or Co-development PartnerCommercial collaborator for bionic eye research and development.
  • Epi-Minder Pty LtdcoreStrategic or Co-development PartnerSpin-off company from Bionics Institute developing implantable continuous monitoring for epilepsy, now listed on ASX.
  • Deep Brain Stimulation Technologies Pty LtdcoreStrategic or Co-development PartnerSpin-off company from Bionics Institute for deep brain stimulation technology.
  • Neo-BionicacoreStrategic or Co-development PartnerSpin-off company providing specialised engineering support to neurotechnology innovators to develop implants from concept to clinical trials.
  • Alfred HealthmajorStrategic or Co-development PartnerClinical collaborator for research projects.
  • Austin HealthmajorStrategic or Co-development PartnerClinical collaborator for research projects.
  • Royal Melbourne HospitalmajorStrategic or Co-development PartnerClinical collaborator for research projects.
  • Monash UniversitymajorStrategic or Co-development PartnerResearch collaborator in the Australian university system.
  • La Trobe UniversitymajorStrategic or Co-development PartnerResearch collaborator in the Australian university system.
  • The University of New South WalesmajorStrategic or Co-development PartnerResearch collaborator in the Australian university system.
  • Oxford UniversitymajorStrategic or Co-development PartnerInternational research collaborator in the UK.
  • Charite Hospital BerlinmajorStrategic or Co-development PartnerInternational research collaborator in Germany.
  • Florey Institute of Neuroscience and Mental HealthmajorStrategic or Co-development PartnerResearch collaborator in neuroscience.
  • Centre for Eye Research Australia (CERA)majorStrategic or Co-development PartnerResearch collaborator for vision-related research.
  • ACMD (Australian Centre for Bioengineering)coreStrategic or Co-development PartnerAustralia's first hospital-based bioengineering research centre located at St Vincents Hospital. Bionics Institute is a key partner and will move into the new ACMD building.
  • Medical Device Partnering Programme (MDPP)minorStrategic or Co-development PartnerNetwork partner for medical device development.
  • VeskiminorStrategic or Co-development PartnerNetwork partner supporting innovation and women in STEM through Girls in STEM Mentoring Program.
  • Epworth HealthcaremajorStrategic or Co-development PartnerClinical collaborator for research projects.
  • The Royal Victorian Eye and Ear HospitalmajorStrategic or Co-development PartnerClinical collaborator for hearing and vision research.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Bionics Institute competitors and assessment

Company assessment

Direct peers

  • NeuroPace: US-based company behind the RNS System, an FDA-approved implantable brain stimulation device for drug-resistant epilepsy. Closest direct peer to Bionics Institute's EpiMinder device, addressing the same patient population with similar implantable neurotechnology architecture.
  • LivaNova: Global neuromodulation company with a leading vagus nerve stimulation (VNS) platform used for drug-resistant epilepsy and treatment-resistant depression. Direct peer to Bionics Institute's vagus nerve stimulation programs and a benchmark for scaling neuromodulation indications.
  • Cochlear Limited: Global leader in cochlear implant devices, headquartered in Australia. Bionics Institute is the original scientific developer of the cochlear implant technology and remains a research collaborator/licensor to Cochlear Limited, making them the most direct peer commercially and scientifically.
  • Advanced Bionics (Sonova): US-based cochlear implant manufacturer (acquired by Sonova). Operates in the same hearing restoration device category as Bionics Institute cochlear research, targeting similar patients and clinical use cases.
  • MED-EL: Austria-based global cochlear implant manufacturer competing directly in the hearing restoration market where Bionics Institute cochlear research operates. Comparable in product category, clinical use case, and patient population.
  • Bionic Vision Technologies: Australian bionic eye developer and listed commercial collaborator of Bionics Institute. Directly comparable for bionic eye research targeting retinitis pigmentosa, with overlapping patient population and technology basis.

Emerging players

  • electroCore: Smaller neuromodulation company commercializing non-invasive vagus nerve stimulation (nVNS) for headache and inflammatory conditions. Overlaps with Bionics Institute's vagus nerve stimulation research but uses a non-invasive delivery approach rather than the institute's implantable method.
  • Saluda Medical: Australia/US neuromodulation company developing closed-loop spinal cord stimulation. Comparable emerging player in the implantable neurostimulation category where Bionics Institute operates, addressing chronic pain and neurological indications.

Broad incumbents

  • Medtronic: Global medical device incumbent with the largest neuromodulation portfolio (spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, targeted drug delivery). Competes broadly with Bionics Institute across multiple pipeline areas including DBS and cochlear-adjacent neurotechnology.
  • Abbott (Neuromodulation): Diversified medical device incumbent with a major neuromodulation franchise (Proclaim spinal cord stimulators, Infinity DBS). Operates in the same broader neuromodulation market as Bionics Institute with vastly greater commercialization scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Bionics Institute social profiles

Digital presence

Bionics Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bionics Institute leadership team

Management profile

Number of profiles

Profiles14 records

Bionics Institute subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Bionics Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bionics Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionics Institute

What does Bionics Institute do?

Bionics Institute is a non-profit medical research institute that develops implantable medical devices and neuromodulation technologies for hearing, vision, neurological and inflammatory conditions. It also provides fee-for-service contract research capabilities spanning pre-clinical studies, histology, engineering and prototype manufacturing, and specialised clinical testing for external researchers, clinicians and industry clients.

Is Bionics Institute a public or private company?

Bionics Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Bionics Institute founded?

Bionics Institute was founded in 1986. It employs 101 to 250 people.

Where is Bionics Institute based?

Bionics Institute is headquartered in Fitzroy, Australia, in the Oceania region.

How does Bionics Institute make money?

Five revenue lines are on record. Donations and Philanthropy is the primary driver. The others are government Grants, impact and Equity Investment, contract Research Services and spin-off Company Revenue.

Who are Bionics Institute's main competitors?

Direct peers on record are NeuroPace, LivaNova, Cochlear Limited, Advanced Bionics (Sonova), MED-EL and Bionic Vision Technologies. Emerging players are electroCore and Saluda Medical. Broad incumbents are Medtronic and Abbott (Neuromodulation).

Does Bionics Institute have an API?

No public API is recorded for Bionics Institute.

What industry is Bionics Institute in?

Bionics Institute's product category is Medical Device Research & Development. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals